Zhuhai HOPEGENES pharmaceutical research institute co. LTD

ADD:Room 1791, no.6, baohua road,

           hengqin new district, zhuhai city

Tel :+86-756-888888

E-mail:hopegenes@163.com

Zhuhai HOPEGENES pharmaceutical research institute co. LTD

 吉ICP备12003232号    Powered by : www.300.cn

 

R&D SERUICES

Immunotherapy

Page view:

The core mechanism of car-t immunotherapy is to specifically identify tumor-related antigens, so that the targeting, killing activity and persistence of effector T cells are significantly higher than those of conventional immune cells, thus breaking the host immune tolerance state, overcoming immune escape and ultimately killing tumor cells.